Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Increase in Short Interest

Aditxt, Inc. (NASDAQ:ADTXGet Rating) was the recipient of a large growth in short interest in the month of August. As of August 31st, there was short interest totalling 2,060,000 shares, a growth of 51.5% from the August 15th total of 1,360,000 shares. Based on an average daily volume of 7,620,000 shares, the short-interest ratio is currently 0.3 days.

Aditxt Stock Performance

Shares of ADTX stock opened at $10.39 on Friday. The company’s fifty day moving average price is $19.81 and its 200-day moving average price is $17.19. Aditxt has a one year low of $6.21 and a one year high of $136.00.

Hedge Funds Weigh In On Aditxt

A hedge fund recently bought a new stake in Aditxt stock. Virtu Financial LLC acquired a new position in shares of Aditxt, Inc. (NASDAQ:ADTXGet Rating) in the 2nd quarter, according to the company in its most recent filing with the SEC. The fund acquired 495,665 shares of the company’s stock, valued at approximately $71,000. Virtu Financial LLC owned approximately 0.90% of Aditxt as of its most recent SEC filing. 4.81% of the stock is currently owned by institutional investors.

Aditxt Company Profile

(Get Rating)

Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.

Further Reading

Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.